EWG Elevate’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

EWG Elevate’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$4.66M	Buy	+46,503	New	+$4.19M	1.46%	23
2024 Q3	–	Sell	-23,289	Closed	-$2.16M	–	138
2024 Q2	$2.16M	Buy	23,289 +20,806	+838%	+$1.87M	0.79%	39
2024 Q1	$236K	Buy	+2,483	New	+$230K	0.09%	111
2023 Q1	–	Sell	-316	Closed	-$26.2K	–	806
2022 Q4	$26.2K	Buy	+316	New	+$25.6K	0.01%	237

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

EWG Elevate's XBI Position: Q3 2025 in Review

EWG Elevate opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q3 2025: 46,503 shares worth $4.66M. The stake represents 1.46% of the portfolio and ranks #23 among its holdings. This is a return to the name: EWG Elevate previously reported a position in XBI as recently as Q2 2024.

EWG Elevate first reported a position in XBI in Q4 2022 and has held it in 4 quarters since. 656 funds tracked by Wall St. Rank hold XBI as of Q3 2025.

EWG Elevate held 46,503 shares of State Street SPDR S&P Biotech ETF worth $4.66M as of Q3 2025.
State Street SPDR S&P Biotech ETF was a new EWG Elevate position in Q3 2025.
State Street SPDR S&P Biotech ETF made up 1.46% of EWG Elevate's portfolio in Q3 2025, its #23 holding.
EWG Elevate first reported a position in State Street SPDR S&P Biotech ETF in Q4 2022 and has held it in 4 quarters since.
656 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2025.

Based on EWG Elevate's 13F filing for Q3 2025, filed 7 Oct 2025.